No abstract available
MeSH terms
-
Anti-Obesity Agents* / adverse effects
-
Anti-Obesity Agents* / economics
-
Appetite / drug effects
-
Appetite Depressants / pharmacology
-
Body Weight / drug effects
-
Cannabinoids / metabolism
-
Drug Approval / legislation & jurisprudence*
-
Drug Industry / economics
-
Drug Industry / legislation & jurisprudence*
-
Humans
-
Lactones / pharmacology
-
Lactones / therapeutic use
-
Obesity / drug therapy*
-
Orlistat
-
United States
-
United States Food and Drug Administration / legislation & jurisprudence
Substances
-
Anti-Obesity Agents
-
Appetite Depressants
-
Cannabinoids
-
Lactones
-
Orlistat